NYSEARCA:IHE

Ishares Us Pharmaceuticals Etf ETF News

etoro logo Buy IHE
*Your capital is at risk
$90.02
+1.03 (+1.16%)
At Close: Jun 03, 2026

Biotech Innovations Remain At Forefront

11:10am, Friday, 16'th Apr 2021
The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively r

Moving Beyond COVID In Biopharma

09:31am, Thursday, 15'th Apr 2021
Just over one year after COVID-19 disrupted our lives, we are now getting to the point where multiple vaccine options are nearly ubiquitous for those in the United States. Per the CDC, as of April 12,
Some biotech and pharmaceutical ETFs are gaining on Tuesday despite news that Johnson and Johnson's coronavirus vaccine has been halted in over two dozen states, after the Food and Drug Administratio
Here we highlight some ETFs with high exposure to Pfizer (PFE) that can gain from the encouraging progress in coronavirus vaccine development as the outbreak worsens.

The Diana Ross 'Upside Down' Stock Market

01:20pm, Thursday, 04'th Mar 2021
Hedge Funds are using AAPL and FAANG as a "source of funds" What's working, not working, and what's next?
The advantage for dividend investors in this sector is the wide choice of large and well-established companies. AbbVie is a drug company with strong exposure to the immunology and the oncology markets

Pharma ETFs in Focus Post Q4 Earnings

01:38pm, Friday, 05'th Feb 2021
Healthcare Q4 results seem robust given that it is the fourth-best sector from a revenue growth look and the sixth-strongest in terms of earnings growth.
The Healthcare sector has significantly outperformed the S&P500 in the last decade and with lower volatility – the only sector to do so.

The Reopening Killed The V-Shaped Recovery

07:43am, Monday, 29'th Jun 2020
This is a weekly series focused on analyzing the previous week’s economic data releases. The objective is to concentrate on leading indicators of economic activ
Advisory Alpha LLC raised its holdings in iShares US Pharmaceuticals ETF (NYSEARCA:IHE) by 93.3% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commi
Centaurus Financial Inc. acquired a new stake in shares of iShares US Pharmaceuticals ETF (NYSEARCA:IHE) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchan
Biotech and healthcare ETFs were pretty stable on Apr 23 despite the news that Gilead's Remdesivir failed to improve Covid-19 patients' condition.
Investors should closely watch the movement of the stock and keep a close eye on ETFs having double-digit allocation to this diversified drug maker post its earnings release.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE